Literature DB >> 4534194

Lytic therapy in vitreous haemorrhage.

J V Forrester, J Williamson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4534194

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


× No keyword cloud information.
  4 in total

1.  Tissue plasminogen activator therapy for the eye.

Authors:  R C Tripathi; B J Tripathi
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  Treatment with urokinase.

Authors: 
Journal:  Br J Ophthalmol       Date:  1977-08       Impact factor: 4.638

3.  Vitreous haemorrhage.

Authors: 
Journal:  Br Med J       Date:  1978-04-15

4.  Urokinase in the management of vitreous hemorrhage.

Authors:  J S Chapman-Smith; G W Crock
Journal:  Br J Ophthalmol       Date:  1977-08       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.